AndronETalksNews
Daily Mail.com
By MARY KEKATOS ACTING U.S. HEALTH EDITOR FOR DAILYMAIL.COM
PUBLISHED: | UPDATED:
The U.S. Food and Drug Administration (FDA) will decide on full approval of Pfizer-BioNTech’s COVID-19 vaccine for those aged 16 and older no later than early next year.
Currently, the two-dose shot is only authorized for emergency use in Americans aged 12 and up.
However, the FDA granted Priority Review to Pfizer-BioNTech’s application, meaning all overall attention and resources are directed at reviewing data on the vaccine.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
